hotspot -WSS

hotspot

author：comprehensive 2025-09-30 18:43:08 - browse：78149

AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July. Gonzalez had previously said he would depart when AbbVie had a plan in place to move on from its best-selling drug, Humira, which is now facing competition from cheaper biosimilars.

He will be replaced by Chief Operating Officer Robert Michael, who, like Gonzalez, is a longtime AbbVie executive. Gonzalez, 70, will become executive chairman of the board of directors.

Gonzalez should be a sobering reminder to the drug industry’s critics of how resilient a CEO’s reputation can be. Because while he has been a subject of nearly constant criticism for AbbVie’s handling of Humira and the patents protecting it, investors are likely to remember him fondly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Juul documents reveal insider tactics on political lobbying

hotspot

WSS

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

CDC advisory group OKs chikungunya vaccine

Long Covid research funding gets a major boost from NIH

Congress must protect the remaining independent doctors

Having children helps parents live longer, especially after age 80

Abbott's new heart device gets FDA advisory panel nod

focus

hotspot

entertainment

Trump demands the U.S. pay no more for drugs than other countries … again

STAT Boddities: What happens to the brain when we get scared?

At least 13 dead in Texas as scorching temps continue

Children’s Hospital revives plan for pedestrian bridge

State Dept. review finds Biden bears some blame for Afghanistan failures

Neuroscience renaissance leads to new crop of psychiatric drugs

Trump demands the U.S. pay no more for drugs than other countries … again

Report cites 'urgent' need to recruit more diverse clinical trial participants

Medical leaders decry Supreme Court decision on affirmative action

Study fuels hope CAR

explore

Redefining sustainability for the pharmaceutical industry

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

CDC advisory group OKs chikungunya vaccine

Elisabeth Bik tackles the widespread issue of research misconduct

NEJM study measures Covid brain fog, impact on IQ

hotspot

focus

leisure time

explore